rebound
Commented by Matthias Schomber on November 4th, 2026 | 05:43 CET
Apple disappoints with its outlook; Aixtron celebrates an order boom and Power Metallic Mines is poised for a rebound!
Prepared and published on behalf of Power Metallic Mines
Global equity markets face important directional decisions in late autumn 2026. Severe dislocations are occurring and have already occurred, most recently to an extreme degree at Intel and other chip stocks. While technology stocks such as Apple are struggling with unexpected margin pressure and expensive memory chips despite stellar record highs, semiconductor equipment manufacturer Aixtron is experiencing a breakthrough thanks to booming order books. Away from the major indices and stocks, the commodities sector is also worth a look. At Power Metallic Mines, a more pronounced consolidation may have laid the groundwork for a rebound to begin now. Strong drilling results and the upcoming PEA could pave the way for expectations of substantial share price gains. Read on to find out how to assess these three stocks in the current market environment.
Read
Commented by Matthias Schomber on October 30th, 2026 | 05:27 CET
BioNTech seeks a breakthrough with its cancer pipeline, DroneShield battles short sellers and Cardiol Therapeutics targets a rebound!
Created and published on behalf of Cardiol Therapeutics
Biotech heavyweights such as BioNTech and defence and drone stocks such as DroneShield are currently looking for unambiguous and clear trend signals. While BioNTech is grappling with clinical setbacks and internal discussions despite strategic collaborations, defence specialist DroneShield is weighed down by persistent short-selling pressure and rather subdued growth expectations. At the same time, Cardiol Therapeutics is coming into focus as a technically promising candidate that, following a correction lasting several months, could now find the long-awaited bottom at a prominent technical support zone. This equity analysis of the 3 stocks examines the financial data, operational milestones and strategic opportunities as well as the risks of the three companies to provide guidance that is as well-founded as possible. Read on to find out where attractive opportunities are now emerging.
Read
Commented by André Will-Laudien on September 8th, 2026 | 09:40 CEST
Biotech: Time to Bet on the Rebound! Evotec and BioNxt in the Takeover Spotlight, Bayer and BioNTech Flush with Cash
After a long dry spell, the biotech sector is on the cusp of a spectacular turnaround, offering bold investors the potential for significant returns. Many innovative biotech stocks are trading well below their all-time highs, yet almost unnoticed, the next major rally is already taking shape behind the scenes. The huge cash reserves of industry giants Bayer and BioNTech are currently fueling takeover speculation across the sector. This colossal capital, running into the billions, is desperately seeking new growth drivers, suddenly putting smaller players on the radar of potential acquirers. At the very top of the hunters' watchlist are the hard-hit Evotec and the disruptive newcomer BioNxt. Both companies boast top-class technology platforms, which, at current levels, almost seem like an exclusive clearance sale. Investors who keep their eyes open and position themselves strategically for the major rebound could get ahead of the looming wave of consolidation. The conditions for an explosive catch-up rally have rarely been this favorable.
Read
Commented by Stefan Feulner on April 2nd, 2026 | 07:05 CEST
SAP, Desert Gold, Novo Nordisk – Strong Rebound Potential
Donald Trump's surprise announcement that he intends to end the Iran conflict is sparking renewed activity in the markets. After weeks of uncertainty and, in some cases, sharp price declines, sentiment is noticeably improving. Many stocks had previously suffered from geopolitical pressure but could now be poised for a strong rebound. Investors are increasingly looking toward a possible easing of tensions, falling risk premiums, and a return of capital to riskier asset classes.
Read
Commented by Armin Schulz on November 22nd, 2023 | 07:10 CET
Siemens Energy, Almonty Industries, BASF - Rebound underway, where is it worth getting in?
At the end of October, the mood among investors was gloomy. Many indices were under pressure and had lost more than 10% of their value. Since October 28, the mood has changed, and the markets have rallied significantly. One of the reasons is undoubtedly the Fed's interest rate pause. After three weeks on the upswing, the indices are approaching new highs. Nevertheless, there are still stocks that have not yet been able to benefit from the upward trend. We have picked out three interesting stocks that offer plenty of long-term potential.
Read
Commented by Stefan Feulner on June 15th, 2023 | 08:35 CEST
Lufthansa, Tocvan Ventures, Aurubis - Optimism is growing
In the run-up to the interest rate decision in the US, investors were in a buying mood and lifted Germany's leading index, the DAX, to a new all-time high. The fact that the monetary guardians are stopping short of further increases in this interest rate cycle offers room for further price gains. The travel industry, which has been badly hit by the Corona pandemic, is also receiving a tailwind. The sharp drop in share prices in the recent past should offer attractive entry opportunities at the current level.
Read